Literature DB >> 7965790

Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors.

M F O'Rourke1, L J Iversen, J W Lomasney, D B Bylund.   

Abstract

Four pharmacological subtypes of the alpha-2 adrenergic receptor have been identified; however, only three subtypes exist in any given species. Although the alpha-2A adrenergic receptor, as defined by the human platelet, and the alpha-2D receptor, as defined in the bovine pineal, have very different pharmacological characteristics, they are more similar to each other than either is to the alpha-2B or alpha-2C subtype. The human alpha-2-C10 clone (alpha-2A) and the rat RG20 clone have an 89% identity in their predicted amino acid sequence and are considered to be species orthologs. Although the expressed RG20 clone appears to have alpha-2D pharmacology, a careful comparison of its pharmacological characteristics with the bovine pineal has not been reported previously. Based on the pKi values of a panel of 13 alpha-2 adrenergic agents that have been used previously to compare the alpha-2A, alpha-2B and alpha-2C subtypes, the pharmacological characteristics of the bovine pineal alpha-2D receptor appear to be very similar to the rat RG20 clone (correlation coefficient, r, of 0.93). The porcine ortholog of the human alpha-2-C10 receptor has pharmacological characteristics identical to the human alpha-2A receptor (r = 0.99). Because of its higher affinity for the alpha-2D receptor, [3H]RX821002 is a better radioligand than [3H]rauwolscine for studying this receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7965790

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

Review 1.  Evolution of the membrane guanylate cyclase transduction system.

Authors:  Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

2.  Antagonists that differentiate between alpha 2A-and alpha 2D-adrenoceptors.

Authors:  A U Trendelenburg; C A Wahl; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

Review 3.  Alpha-2 adrenoceptor subtypes: are more better?

Authors:  David B Bylund
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

Review 4.  Membrane guanylate cyclase is a beautiful signal transduction machine: overview.

Authors:  Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2009-12-03       Impact factor: 3.396

Review 5.  ROS-GC subfamily membrane guanylate cyclase-linked transduction systems: taste, pineal gland and hippocampus.

Authors:  Rameshwar K Sharma; Teresa Duda
Journal:  Mol Cell Biochem       Date:  2009-12-02       Impact factor: 3.396

6.  Presynaptic alpha2-adrenoceptors control excitatory, but not inhibitory, transmission at rat hippocampal synapses.

Authors:  S Boehm
Journal:  J Physiol       Date:  1999-09-01       Impact factor: 5.182

7.  Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation.

Authors:  X F Figueroa; M I Poblete; M P Boric; V E Mendizábal; E Adler-Graschinsky; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

8.  No evidence for functional imidazoline receptors on locus coeruleus neurons.

Authors:  B Szabo; R Fröhlich; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

Review 9.  Neurocognitive Disorders in Heart Failure: Novel Pathophysiological Mechanisms Underpinning Memory Loss and Learning Impairment.

Authors:  C Toledo; D C Andrade; H S Díaz; N C Inestrosa; R Del Rio
Journal:  Mol Neurobiol       Date:  2019-06-05       Impact factor: 5.590

10.  Molecular and pharmacological identity of the alpha 2D-adrenergic receptor subtype in bovine retina and its photoreceptors.

Authors:  V Venkataraman; T Duda; K Galoian; R K Sharma
Journal:  Mol Cell Biochem       Date:  1996-06-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.